Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent Nivolumab and External Beam Radiation Therapy for Advanced Hepatocellular Carcinoma with Vascular Invasion
KCT0004483Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Jan 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in hepatocellular carcinoma (HCC), sponsored by Ono Pharmaceutical. Started Jan 2020; status: completed.
02
Drugs
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on KCT0004483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004483.